Can CYN sustain its Q1 2024 EPS growth?

**CYN's ability to sustain its Q1 2024 EPS growth is uncertain**. Here's why:

1. **Revenue Decline and Negative Net Margin**: The company's revenue has declined from $1.49 million in Q3 2023 to $368,138 in Q4 2024. Concurrently, the net margin has been negative, with a significant drop from -1531.66% to -7946.01%. Such a trend in revenue reduction and negative margins raises concerns about the company's financial health and its ability to support EPS growth.

|code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code|
|---|---|---|---|---|---|---|
|CYN|CYN.O|Cyngn|2022 Q4||262000|186|
|CYN|CYN.O|Cyngn|2023 Q1||872800|186|
|CYN|CYN.O|Cyngn|2023 Q2||550952|186|
|CYN|CYN.O|Cyngn|2023 Q3||25210|186|
|CYN|CYN.O|Cyngn|2023 Q4|-84.5969465648855|40356|186|
|CYN|CYN.O|Cyngn|2024 Q1|-99.36835472043997|5513|186|
|CYN|CYN.O|Cyngn|2024 Q2|-98.42726771116178|8665|186|
|CYN|CYN.O|Cyngn|2024 Q3|88.75049583498613|47584|186|
|CYN|CYN.O|Cyngn|2024 Q4|659.1832689067301|306376|186|

|code|Ticker|Name|Date|Net Profit Margin YoY|Net Profit Margin|market_code|
|---|---|---|---|---|---|---|
|CYN|CYN.O|Cyngn|2022 Q4||-7342.179|186|
|CYN|CYN.O|Cyngn|2023 Q1||-644.9081|186|
|CYN|CYN.O|Cyngn|2023 Q2||-841.5902|186|
|CYN|CYN.O|Cyngn|2023 Q3||-1204.5644|186|
|CYN|CYN.O|Cyngn|2023 Q4|79.13893000974234|-1531.6571|186|
|CYN|CYN.O|Cyngn|2024 Q1|-16691.684039943055|-108290.9305|186|
|CYN|CYN.O|Cyngn|2024 Q2|-9779.428847911962|-83144.305|186|
|CYN|CYN.O|Cyngn|2024 Q3|-2214.151173652484|-27875.4412|186|
|CYN|CYN.O|Cyngn|2024 Q4|-418.78520982274694|-7946.0105|186|

|code|Ticker|Name|Date|Basic Earnings per Share YoY|Basic Earnings per Share|market_code|
|---|---|---|---|---|---|---|
|CYN|CYN.O|Cyngn|20220331|91.41104294478527|-0.14|186|
|CYN|CYN.O|Cyngn|20220630|92.42819843342036|-0.29|186|
|CYN|CYN.O|Cyngn|20220930|93.09764309764309|-0.41|186|
|CYN|CYN.O|Cyngn|20221231|53.383458646616546|-0.62|186|
|CYN|CYN.O|Cyngn|20230331|-21.428571428571423|-0.17|186|
|CYN|CYN.O|Cyngn|20230630|-24.13793103448276|-0.36|186|
|CYN|CYN.O|Cyngn|20230930|-14.634146341463413|-0.47|186|
|CYN|CYN.O|Cyngn|20231231|8.064516129032265|-0.57|186|
|CYN|CYN.O|Cyngn|20240331|52.94117647058824|-0.08|186|
|CYN|CYN.O|Cyngn|20240630|-3275.000000000001|-12.15|186|

2. **Financial Performance**: Cyngn reported a net loss of $29.3 million for the year ending December 31, 2024, with an accumulated deficit of $189.3 million as of the same date. The loss from operations was $22.8 million, indicating a substantial financial burden that could impact the company's ability to sustain EPS growth.
3. **Liquidity and Market Capitalization**: With a market capitalization of $8.13 million and a beta of 1.05, Cyngn's liquidity position is relatively weak. The company's reliance on financing activities to improve its cash position may limit its ability to invest in growth initiatives that could support EPS growth.

|code|Ticker|Name|Date|Market Cap|market_code|
|---|---|---|---|---|---|
|CYN|CYN.O|Cyngn|20240410|1.4024139139E7|186|
|CYN|CYN.O|Cyngn|20240411|1.3845487685E7|186|
|CYN|CYN.O|Cyngn|20240412|1.2952230415E7|186|
|CYN|CYN.O|Cyngn|20240415|1.0093807151E7|186|
|CYN|CYN.O|Cyngn|20240416|9021898.427|186|
|CYN|CYN.O|Cyngn|20240417|9111224.154|186|
|CYN|CYN.O|Cyngn|20240418|9647178.516|186|
|CYN|CYN.O|Cyngn|20240419|9647178.516|186|
|CYN|CYN.O|Cyngn|20240422|1.0808412967E7|186|
|CYN|CYN.O|Cyngn|20240423|1.0190532732E7|186|

|code|Ticker|Name|Date|Beta|market_code|
|---|---|---|---|---|---|
|CYN|CYN.O|Cyngn|20240830|-1.89|186|
|CYN|CYN.O|Cyngn|20240903|-1.94|186|
|CYN|CYN.O|Cyngn|20240905|-1.94|186|
|CYN|CYN.O|Cyngn|20240910|-1.94|186|
|CYN|CYN.O|Cyngn|20240918|-1.94|186|
|CYN|CYN.O|Cyngn|20240919|-1.94|186|
|CYN|CYN.O|Cyngn|20240920|-1.94|186|
|CYN|CYN.O|Cyngn|20240925|-1.94|186|
|CYN|CYN.O|Cyngn|20240927|-1.94|186|
|CYN|CYN.O|Cyngn|20241004|-1.92|186|

4. **Strategic Initiatives**: While Cyngn has secured patents and made strategic partnerships, the effectiveness of these initiatives in improving profitability and sustaining EPS growth is yet to be seen. The company's focus on developing autonomous vehicle technology for industrial applications is promising but requires significant investment and market acceptance to translate into financial growth.
5. **Nasdaq Compliance**: Cyngn's recent regaining of compliance with Nasdaq's listing requirements is a positive sign, but it does not guarantee the company's ability to sustain EPS growth. The company's common stock will continue to be listed and traded on Nasdaq, which is a prerequisite for any potential growth but does not guarantee it.

In conclusion, while Cyngn has made strides in securing patents and partnerships, the decline in revenue, negative net margins, and financial losses suggest that sustaining EPS growth in Q1 2024 and beyond will be challenging. The company's focus on strategic initiatives and regulatory compliance is crucial, but it remains to be seen how these will translate into financial growth and EPS sustainability.